OssDsign AB Logo

OssDsign AB

Developer of orthobiologics for bone regeneration in spinal fusion surgery.

OSSD | ST

Overview

Corporate Details

ISIN(s):
SE0012570448
LEI:
5493005SNS5NAYE2WL53
Country:
Sweden
Address:
Ulls väg 29C, 756 51 Uppsala

Description

OssDsign is a developer and global provider of next-generation orthobiologics products based on advanced material science. The company develops and markets products that support the body's own healing capabilities, with a primary focus on bone regeneration for spinal fusion surgery. Its flagship product, OssDsign Catalyst®, is a nanosynthetic bone graft putty engineered to engage dual bone formation pathways, promoting rapid and reliable bone formation. OssDsign Catalyst® is the first synthetic bone graft to receive clearance for on-label interbody use based on bone graft data alone, allowing it to be used in any interbody cage cleared for use with synthetic bone grafts. This unique regulatory status, combined with its handling characteristics, differentiates the product in the orthobiologics market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all OssDsign AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OssDsign AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OssDsign AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BRISTOL MYERS SQUIBB CO Logo
A global biopharmaceutical company that discovers, develops, and commercializes medicines.
United States of America
BMY
An R&D-focused company developing drugs for CNS disorders and oncology.
South Korea
003000
C4 Therapeutics, Inc. Logo
Clinical-stage biopharma developing targeted protein degradation therapeutics.
United States of America
CCCC
Cadrenal Therapeutics, Inc. Logo
A late-stage biopharmaceutical company developing novel anticoagulation therapeutics.
United States of America
CVKD
CalciMedica, Inc. Logo
Develops CRAC channel inhibitors for acute inflammatory and immunologic diseases.
United States of America
CALC
Calidi Biotherapeutics, Inc. Logo
Develops stem cell platforms to deliver oncolytic viruses for cancer therapy.
United States of America
CLDI
Calliditas Therapeutics Logo
Biopharma company developing and commercializing treatments for rare diseases.
Sweden
CALTX
CALTH. Inc Logo
Develops in vitro diagnostic tools for point-of-care and self-testing.
South Korea
402420
Cambrex Logo
A CDMO providing drug substance, drug product, and analytical services.
United States of America
CBM
CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo
Develops and manufactures diagnostic tests for food sensitivity and gut health.
United Kingdom
CNSL

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.